Bottom line
How much do PPH and SCHLX overlap?
50% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 75.8% of PPH's assets and 44.2% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
SCHLX holds far more positions (65 vs 26), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PPH and SCHLX have in common
| Holding | % of PPH | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 20.23% | 13.85% | 13.85% |
| Novartis AG | 10.63% | 2.90% | 2.90% |
| Merck & Co Inc | 9.85% | 4.85% | 4.85% |
| Novo Nordisk A/S | 5.37% | 1.73% | 1.73% |
| AbbVie Inc | 4.57% | 4.90% | 4.57% |
| Pfizer Inc | 4.51% | 1.17% | 1.17% |
| Bristol-Myers Squibb Co | 4.47% | 1.50% | 1.50% |
| Johnson & Johnson | 4.35% | 6.19% | 4.35% |
| AstraZeneca PLC | 4.33% | 3.80% | 3.80% |
| McKesson Corp | 4.12% | 2.05% | 2.05% |
| Cencora Inc | 3.36% | 1.26% | 1.26% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PPH
- Gsk Plc — 4.42%
- Sanofi SA — 4.00%
- Haleon PLC — 3.09%
- Teva Pharmaceutical Industries Ltd — 3.06%
- Takeda Pharmaceutical Co Ltd — 2.87%
- Zoetis Inc — 2.10%
- Viatris Inc — 1.10%
- Jazz Pharmaceuticals PLC — 1.08%
- Axsome Therapeutics Inc — 0.77%
- Corcept Therapeutics Inc — 0.50%
- Elanco Animal Health Inc — 0.35%
- State Street Global Advisors — 0.28%
- Organon & Co — 0.23%
- Bausch Health Cos Inc — 0.10%
Only in SCHLX
- UnitedHealth Group Inc — 5.73%
- Thermo Fisher Scientific Inc — 3.46%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
- Intuitive Surgical Inc — 2.69%
- Stryker Corp — 2.61%
- Vertex Pharmaceuticals Inc — 2.45%
- Abbott Laboratories — 2.39%
- Danaher Corp — 2.13%
- Boston Scientific Corp — 2.10%
- Medtronic PLC — 1.54%
- Regeneron Pharmaceuticals Inc — 1.43%
- Cardinal Health Inc — 1.34%
- Roche Holding AG — 1.24%
Asset mix
| Asset type | PPH | SCHLX |
|---|---|---|
| Stocks | 99.5% | 99.6% |
| Cash & short-term funds | 0.3% | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | PPH | SCHLX |
|---|---|---|
| US | 60.8% | 85.7% |
| GB | 11.8% | 3.8% |
| CH | 10.6% | 5.2% |
| DK | 5.4% | 1.7% |
| FR | 4.0% | 1.0% |
| IL | 3.1% | — |
| JP | 2.9% | — |
| IE | 1.1% | 1.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PPH and SCHLX overlap?
What stocks do PPH and SCHLX have in common?
Should I own both PPH and SCHLX?
Which holds more stocks, PPH or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.